The current US flu season is shaping up to be among the worst in decades; a single dose of the HPV vaccine shows efficacy in an analysis; generic manufacturers plan to appeal a California ruling on pay-to-delay deals.
As reported by CNN, the current US flu season is shaping up to be among the worst in decades. The United States’ top infectious disease doctor, Anthony Fauci, MD, director of the National Institute of Allergies and Infectious Diseases, stated, “The initial indicators indicate this is not going to be a good season — this is going to be a bad season.” So far, this flu season has caused at least 2900 deaths in the US and is on track to be as severe as the 2017-2018 flu season, which was the deadliest in more than 4 decades.
An analysis published in JAMA Open Network found that women aged 18 to 26 who got only 1 dose of the human papillomavirus (HPV) vaccine, as opposed to the recommended 3, showed benefits against cancer-causing HPV, according to The New York Times. The prevalence of HPV infection was significantly higher among the 62% who were unvaccinated, but the study showed no significant difference between the rates among those with a single dose versus all 3. Researchers noted that while the results are encouraging, until clinical trials have tested the efficacy of 1 dose, people should continue to receive the recommended dose.
After a federal judge declined to block a new California law that bans the so-called “pay-to-delay” deals between drug makers, a trade group within the pharmaceutical industry plans to pursue an appeal in a higher court, according to STAT. The initial lawsuit came from the Association for Accessible Medicines 2 months ago, with California officials explaining that the law intends to prevent drug companies from impeding competition and maintaining higher prices for medicines.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More